Telemedicine in the Era of COVID-19
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Digital Health".
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 32634
Special Issue Editor
Interests: telemedicine; pharmacy; telepharmacy; overweight/obesity; chronic diseases; non-communicable diseases; public health; ethical and legal challenges and COVID-19
Special Issue Information
Dear Colleagues,
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing the deadly coronavirus disease 2019 (COVID-19), is a member of a large family of viruses—coronaviruses—that cause various diseases of the pulmonary system ranging from the common cold to severe respiratory syndromes such as the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). COVID-19 afflicts all age groups; in particular, 95% of deaths have occurred in people over the age of 60. In preventing this COVID-19 deadly pandemic, telemedicine can help by enabling mildly ill patients to receive the supportive care they need while minimizing their exposure to other seriously ill patients. Hence, in promoting telemedicine during the COVID-19 era, it is important to reduce the spread of viruses and support public health measures. In this Special Issue, the management of patients with COVID-19 and how to reduce the infection rate using telemedicine technology are discussed. Therefore, an evidence-based prevention strategy is essential to reduce mortality and morbidity due to the COVID-19 pandemic, particularly through the use of telemedicine technologies.
Dr. Giulio Nittari
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- SARS-CoV-2
- digital health
- digital medicine
- public health
- surveillance
- telehealth
- telemedicine